{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-018156","form_type":"8-K","ticker":"ZVSA","cik":"0001859007","company_name":"ZyVersa Therapeutics, Inc.","filed_at":"2025-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.847163+00:00","generated_at":"2026-05-17T03:47:06.798403+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ZyVersa CMO Pablo Guzman resigns Oct 10, 2025 to focus on family","bullets":["Pablo Guzman, M.D., resigned as CMO and SVP of Medical Affairs, effective October 10, 2025.","Dr. Guzman joined ZyVersa in January 2015 with over 35 years of medical experience.","Resignation reason: personal (spend time with family and travel); no replacement announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-018156","json":"https://secwatch.observer/filing/0001493152-25-018156.json","markdown":"https://secwatch.observer/filing/0001493152-25-018156.md","text":"https://secwatch.observer/filing/0001493152-25-018156.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859007/000149315225018156/0001493152-25-018156-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859007/000149315225018156/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:47:06.798403+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}